

(Photo by sasirin pamai on Shutterstock)
All 50 States Show Rising Rates of Avoidable Death, While Comparable Countries Improve
In a nutshell
- Every single U.S. state saw increasing rates of avoidable deaths from 2009-2019, while most comparable countries improved their rates during the same period.
- Despite spending twice as much on healthcare as other developed nations, the U.S. shows no correlation between higher healthcare spending and better health outcomes.
- Most of America’s increasing death rates came from preventable causes rather than treatable ones, with drug-related deaths accounting for 71% of the rise in deaths from external causes.
PROVIDENCE, R.I. — More money doesn’t mean better health—at least not in America. An eye-opening study reveals that Americans are dying from preventable and treatable causes at increasing rates compared to citizens of other wealthy nations, despite the U.S. outspending every other country on healthcare.
This research, led by researchers from Brown University and published in JAMA Internal Medicine, compared death rates from avoidable causes across all 50 US states and Washington DC against 40 countries in Europe and the developed world over 12 years (2009-2021).
The Troubling Trend: Every U.S. State Getting Worse
Between 2009 and 2019—before COVID-19 struck—every single US state saw increases in deaths that medical experts consider “avoidable.” These include deaths from conditions that could be prevented through good public health measures or treated effectively with proper medical care. Meanwhile, most other wealthy countries were saving more lives from these same conditions.
When researchers examined the relationship between healthcare spending and outcomes, they discovered other countries consistently get better results when they spend more money. In the United States? No such connection exists. American healthcare dollars simply don’t translate to saved lives the way they do elsewhere.
West Virginia experienced the most dramatic deterioration, with nearly 100 additional avoidable deaths per 100,000 people over the decade. Even New York, which performed best among U.S. states, still showed an increase of 4.9 deaths per 100,000. Meanwhile, countries like Lithuania, Latvia, Estonia, and Hungary—which started with higher death rates—made remarkable improvements.
The increase in U.S. avoidable deaths came primarily from preventable rather than treatable causes. Deaths from external factors—traffic accidents, homicides, suicides, and substance abuse—drove much of the increase, with drug-related deaths accounting for 71% of this rise.
When COVID Hit: A System Already in Trouble
COVID-19 amplified existing weaknesses. From 2019 to 2021, US states suffered far greater increases in avoidable deaths (median: 101.5 additional deaths per 100,000) than other countries (median: 25.8 additional deaths per 100,000).
States and countries that already had higher death rates before the pandemic generally fared worse during the crisis, revealing how existing systemic problems become more apparent when stressed.
Beyond direct COVID-19 deaths, the pandemic period saw increases in avoidable deaths from other causes, including heart disease and accidents. This pattern indicates that disruptions in care and other pandemic impacts further undermined population health.


The Money Paradox: Spending More, Getting Less
The disconnect between spending and outcomes raises fundamental questions about American healthcare. The U.S. already spends roughly twice as much per capita on healthcare as other high-income countries, yet this massive investment isn’t preventing deaths that modern healthcare systems should be able to address.
Researchers say our problems extend beyond clinical care. The evidence points to failures in addressing social factors that influence health outcomes. State-level policy differences—regarding healthcare coverage, reproductive health, taxation, social welfare programs, and other factors—have become more pronounced over the past decade, potentially contributing to the growing variation in outcomes between states.
Still, the fact that even the best-performing U.S. states lag behind most comparable countries shows the problem is national rather than merely regional issues. “There’s been a lot of discussion about preventable deaths in the U.S. such as drug-related deaths or suicides, which do account for a big proportion of this trend,” says lead study author Irene Papanicolas, a professor of health services, policy and practice at Brown’s School of Public Health, in a statement. “However, we found that deaths from nearly all major categories are increasing.”
Looking Forward: Beyond Traditional Healthcare Solutions
The findings emphasize that improving U.S. health outcomes will require action beyond traditional healthcare delivery. Policies affecting nutrition, harmful products, obesity prevention, gun violence, vehicle safety, and other public health measures may be as important as medical care itself.
For everyday Americans, the implications are sobering. Your chances of surviving a preventable or treatable condition are significantly better in almost any other developed country than in the United States—regardless of which state you live in or how much your state spends on healthcare.
“We’ve known for some time that life expectancy has been getting worse in the U.S., but now we can see that the country is on a different trajectory from other high-income countries,” says Papanicolas, who is also the director of the Center for Health System Sustainability. “Other countries are getting better at reducing avoidable deaths through prevention and treatment, but in the U.S., these deaths are growing.”
As life expectancy in the U.S. continues to falter while other nations progress, this research points to the need for fundamental reforms to address what has become a national health crisis affecting every state in the union.
Points Of Contention
While the study provides important insights into comparative health outcomes, several methodological and interpretive concerns should be considered before drawing firm conclusions:
Definition and Classification Challenges
The classification of deaths as “avoidable” involves judgment calls that may not fully capture healthcare system effectiveness. The researchers categorized all COVID-19 deaths as “preventable,” which oversimplifies a complex reality where some deaths might have been unavoidable regardless of healthcare quality. Similarly, the cutoff age of 75 years for “avoidable” deaths is somewhat arbitrary and excludes many potentially preventable deaths in older populations, which could skew comparisons between countries with different age distributions.
Data Quality and Comparability Issues
Death certificate coding practices vary substantially across countries and even between U.S. states, potentially creating artificial differences in reported avoidable mortality rates. The study notes that several countries had incomplete data reporting (Bulgaria at 86.5%, Turkey at 89.5%, and Cyprus at 98%), which could affect the validity of comparisons. Additionally, several countries were missing data for the final pandemic years, reducing the reliability of post-2019 comparisons.
Confounding Variables Not Fully Addressed
While the researchers adjusted for age and sex differences, many other demographic and social factors that influence mortality weren’t fully accounted for. The U.S. has greater socioeconomic inequality, racial/ethnic diversity, and geographic variation than many comparison countries. These differences might explain some mortality disparities independent of healthcare system performance.
Healthcare Spending Measurement Limitations
The study notes that U.S. state healthcare expenditure data likely underestimates total healthcare costs by excluding administrative costs of private health insurance, public health activities, and research investments. This undercounting could affect the analysis of the relationship between spending and outcomes, potentially masking spending inefficiencies or misallocations.
Correlation vs. Causation
The researchers appropriately acknowledge they can only identify patterns, not prove causation. While the data shows U.S. states have worse outcomes despite high spending, determining exactly why requires additional research. Cultural factors, lifestyle differences, environmental exposures, and policy priorities all influence health outcomes but weren’t fully analyzed in this study.
Pandemic Effects Complicate Analysis
The inclusion of the COVID-19 pandemic period (2019-2021) introduces unique challenges. Healthcare systems faced unprecedented stresses during this time, and countries varied widely in their pandemic responses, testing capacities, and reporting practices. These variations might exaggerate or obscure underlying differences in healthcare system effectiveness.
While these limitations don’t invalidate the study’s core findings, they suggest we should interpret the results cautiously. The consistent pattern of worsening avoidable mortality across all U.S. states compared to improvements in other countries remains concerning, but the precise causes and potential solutions may be more complex than the data alone can reveal.
Paper Summary
Methodology
Researchers tracked deaths among people under 75 years old that could have been prevented through good public health measures or treated with proper medical care. Using data from the World Health Organization for international comparisons and the CDC for U.S. states, they compared these “avoidable deaths” across all 50 states plus Washington DC and 40 high-income countries from 2009 to 2021. They adjusted the numbers for age and sex differences between populations and analyzed trends before COVID-19 (2009-2019) and during the pandemic (2019-2021) separately. They also examined whether regions that spent more on healthcare had fewer avoidable deaths.
Results
The research found that between 2009 and 2019, avoidable deaths increased across all US states, with a median rise of 29 deaths per 100,000 people. This ranged from a small increase of 4.9 in New York to an alarming 99.6 in West Virginia. During the same period, most comparison countries saw improvements, with a median decrease of 14.4 deaths per 100,000. The US trend was primarily driven by preventable deaths (median increase of 24.3 per 100,000) rather than treatable deaths (median increase of 7.5 per 100,000). External causes—particularly accidents, homicides, suicides, and substance abuse—contributed most to this rise, with drug-related deaths accounting for 71% of the increase in this category. During COVID-19 (2019-2021), avoidable deaths rose sharply everywhere but much more in U.S. states (median increase of 101.5 per 100,000) than in comparison countries (median increase of 25.8 per 100,000). A striking finding was the relationship between healthcare spending and outcomes: among other high-income countries, higher spending consistently corresponded with lower death rates (correlation coefficient of -0.7), but no such relationship existed among US states, suggesting fundamental inefficiencies in how American healthcare dollars are used.
Funding Information
The researchers disclosed their funding sources and potential conflicts of interest. Dr. Papanicolas reported receiving grants from organizations including the Commonwealth Fund, The Health Foundation, and National Institutes of Health, plus personal fees from the World Health Organization, World Bank, and National Academies of Sciences, Engineering, and Medicine for work unrelated to this study. Dr. Figueroa reported receiving grants from various organizations including the Commonwealth Fund, NIH, Episcopal Health Foundation, U.S. Department of Veterans Affairs, Arnold Ventures Foundation, and Robert Wood Johnson Foundation, along with fees from Project HOPE for serving as a health affairs associate editor. No other conflicts were reported.
Publication Details
This research, “Avoidable Mortality Across US States and High-Income Countries,” was published online in JAMA Internal Medicine on March 24, 2025. The authors—Irene Papanicolas, PhD, Maecey Niksch, BA, and Jose F. Figueroa, MD, MPH—are affiliated with the Department of Health Services, Policy & Practice at Brown University School of Public Health, and the Department of Health Policy and Management at Harvard T.H. Chan School of Public Health and Brigham and Women’s Hospital at Harvard Medical School. The digital identifier (DOI) for the paper is 10.1001/jamainternmed.2025.0155.